Sunitinib and pazopanib for non-clear cell and sarcomatoid kidney cancer
Non-clear cell renal cell carcinoma (RCC) and sarcomatoid renal cell [...]
Non-clear cell renal cell carcinoma (RCC) and sarcomatoid renal cell [...]
A recent study looked at the impact of stopping sunitinib [...]
This interview with Dr Monty Pal, Associate Professor from the [...]
Results from the JAVELIN Renal 101 study to evaluate avelumab [...]
Results from a post-hoc analysis of JAVELIN-Renal 101 in patients [...]
Results from the JAVELIN-Renal 101 clinical trial to assess avelumab [...]
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]
A recent study published in Clinical Cancer Research analysed tumour [...]
A combination of ilixadencel plus sunitinib has shown a complete [...]
Based on the findings from the pivotal phase 3 KEYNOTE-426 [...]